Phase trial piritrexim capsules prolonged low-dose oral administration treatment advanced malignancies phase trial piritrexim use prolonged low-dose oral schedule number different regimens daily days days drug therapy continuous dosing daily days consecutive weeks week rest Dose escalation dosing frequency day day times day number days administration patients advanced cancer study twenty-four courses assessable Myelosuppression dose-limiting toxic effect Other toxic effects stomatitis nausea vomiting anorexia diarrhea skin rash fatigue elevation liver transaminase levels Antitumor activity patients melanoma bladder cancer disease stabilization sarcoma pheochromocytoma recommended dosing schedule phase II clinical trials mg times day days consecutive weeks week drug therapy 